Katie Holliday asks Dalton Strategic Partnership's CEO Magnus Spence how the firm has coped with the passing of its charismatic co-founder Andrew Dalton.
Neptune UK Mid Cap fund manager Mark Martin looks at the prospects for companies in the out of favour pharmaceutical industry.
Brewin Dolphin's John Newlands explains why investors should stick with veteran managers even when new and exciting opportunities enter the market.